(Q34182013)

31 July 2017

1 reference

title

Paediatric uses of atypical antipsychotics (English)

1 reference

31 July 2017

Findling RL

1

1 reference

31 July 2017

McNamara NK

series ordinal

2

1 reference

31 July 2017

Gracious BL

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

Expert Opinion on Pharmacotherapy

31 July 2017

1 reference

31 July 2017

1

1 reference

31 July 2017

5

1 reference

31 July 2017

935-945

1 reference

Prescribing practices of outpatient child psychiatrists

31 July 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.935

The antipsychotics. A pediatric perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.935

An open trial of clozapine in 11 adolescents with childhood-onset schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.935

Clozapine in the treatment of a young adolescent with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.935

Clozapine for tardive dyskinesia in adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.935

Clozapine for early developmental delays with childhood-onset schizophrenia: protocol and 15-month outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.935

Quetiapine for refractory schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.935

Risperidone treatment for juvenile bipolar disorder: a retrospective chart review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.935

Case study: risperidone treatment of children and adolescents with developmental disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.935

Risperidone and explosive aggressive autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.935

Risperidone treatment of children and adolescents with pervasive developmental disorders: a prospective open-label study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.935

An open trial of risperidone in young autistic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.935

Suicide among female adolescents: characteristics and comparison with males in the age group 13 to 22 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.935

Adverse effects of clomipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.935

Childhood-onset schizophrenia: an open-label study of olanzapine in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.935

Olanzapine for autistic disorder with hyperactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.935

Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.935

Quetiapine for refractory mania in a child.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.5.935

21 January 2018

Identifiers

DOI

10.1517/14656566.1.5.935

1 reference

release_y4ofexvf2fc7joaq4jzf4fcnsy

31 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/y4ofexvf2fc7joaq4jzf4fcnsy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference